View More View Less
  • 1 University of Life Sciences in Lublin Department and Clinic of Animal Surgery, Faculty of Veterinary Medicine Lublin Poland
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $836.00

Angiogenesis plays an essential role in the development of a neoplastic tumour by conditioning both its growth and the formation of metastases. The induction of blood vessel growth occurs under the influence of proangiogenic factors, among which Vascular Endothelial Growth Factor (VEGF) seems to be the most important. The aim of this research was to study the level of VEGF measured by ELISA in the serum of dogs with neoplasms of the oral cavity. The study material comprised samples of neoplastic tissue from 17 operated dogs and the serum of the examined animals as well as of dogs from the control group. The tissue samples were taken from dogs of different breeds, aged 6–14 years. The tumour type was determined in accordance with the applicable WHO classification. Blood samples taken from sick dogs and from animals of the control group were centrifuged, and immunoenzymatic labelling of VEGF was performed in the obtained serum using ELISA and R&D system reagents (Quantikine Canine VEGF). All stages of VEGF labelling were performed according to the recommendation of the test manufacturer. The median of VEGF in the serum of the dogs with neoplasms of the oral cavity was 40.64 pg/mL. The lowest value of 14.26 pg/mL was observed in the case of fibrosarcoma, and the highest value of 99.19 pg/mL in the case of squamous cell carcinoma. The VEGF median in the control group amounted to 11.14 pg/mL whereas the VEGF value in the groups of animals diagnosed with benign tumours ranged between 2.30 and 19.74 pg/mL. Elevated VEGF in the blood serum, in comparison with the benign tumour group and the control group, was observed in all examined neoplasms of the oral cavity. It was suggested that overexpression of VEGF can have a prognostic value and is useful in the early detection of neoplasms.

  • Ascierto, P. A., Leonardi, E., Ottaiano, A., Napolitano, M., Scala, S. and Castello, G. (2004): Prognostic value of serum VEGF in melanoma patients: pilot study. Anticancer Res. 24, 4255–4258.

    Castello G. , 'Prognostic value of serum VEGF in melanoma patients: pilot study ' (2004 ) 24 Anticancer Res. : 4255 -4258.

    • Search Google Scholar
  • Bałan, B. J. and Słotwiński, R. (2008): VEGF and tumor angiogenesis. Centr. Eur. J. Immunol. 33, 232–236.

    Słotwiński R. , 'VEGF and tumor angiogenesis ' (2008 ) 33 Centr. Eur. J. Immunol. : 232 -236.

    • Search Google Scholar
  • Bergman, P. J. (2007): Canine oral melanoma. Clin. Tech. Small. Anim. Pract. 22, 55–60.

    Bergman P. J. , 'Canine oral melanoma ' (2007 ) 22 Clin. Tech. Small. Anim. Pract. : 55 -60.

  • Dvorak, H. F. (2002): Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and potential target for diagnosis and therapy. J. Clin. Oncol. 20, 4368–4380.

    Dvorak H. F. , 'Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and potential target for diagnosis and therapy ' (2002 ) 20 J. Clin. Oncol. : 4368 -4380.

    • Search Google Scholar
  • Dvorak, H. F., Nagy, J. A., Dvorak, J. T. and Dvorak, A. M. (1988): Identification and characterization of the blond vessels of solid tumors that are leaky to circulating macromolecules. Am. J. Pathol. 133, 95–109.

    Dvorak A. M. , 'Identification and characterization of the blond vessels of solid tumors that are leaky to circulating macromolecules ' (1988 ) 133 Am. J. Pathol. : 95 -109.

    • Search Google Scholar
  • Ferrara, N. (1999): Molecular and biological properties of Vascular Endothelial Growth Factor. J. Mol. Med. 77, 527–543.

    Ferrara N. , 'Molecular and biological properties of Vascular Endothelial Growth Factor ' (1999 ) 77 J. Mol. Med. : 527 -543.

    • Search Google Scholar
  • Head, K. W., Cullen, J. M., Dubielzig, R. R., Else, R. W., Misdorp, W., Patnaik, A. K., Tateyama, S. and Van der Gaab, I. (2003): Histologic Classification of the Tumors of the Alimentary System of Domestic Animals. Armed Forces Institute of Pathology in co-operation with the American Registry of Pathology and the World Health Organization Collaborating Center for Worldwide Reference on Comparative Oncology, Washington, 2nd series. 1-881041-86-7. 257 pp.

    Gaab I. , '', in Histologic Classification of the Tumors of the Alimentary System of Domestic Animals , (2003 ) -.

  • Iruela-Arispe, M. L. (2008): Endothelial cell activation. In: Figg, W. D. and Folkman, J. (eds) Angiogenesis. An Integrative Approach From Science to Medicine. Springer, New York. pp. 135–143.

    Iruela-Arispe M. L. , '', in Angiogenesis , (2008 ) -.

  • Kato, Y., Asano, K., Mogi, T., Kutara, K., Teshima, K., Edamura, K., Tsumagari, S., Hasegawa, A. and Tanaka, S. (2007): Clinical significance of circulating vascular endothelial growth factor in dogs with mammary gland tumors. J. Vet. Med. Sci. 69, 77–80.

    Tanaka S. , 'Clinical significance of circulating vascular endothelial growth factor in dogs with mammary gland tumors ' (2007 ) 69 J. Vet. Med. Sci. : 77 -80.

    • Search Google Scholar
  • Łojko, A. and Komarnicki, M. (2004): Vascular endothelial growth factor in tumor angiogenesis. Współcz. Onkol. 8, 1–4.

    Komarnicki M. , 'Vascular endothelial growth factor in tumor angiogenesis ' (2004 ) 8 Współcz. Onkol. : 1 -4.

    • Search Google Scholar
  • López de Cicco, R., Watson, J. C., Bassi, D. E., Litwin, S. and Klein-Szanto, A. J. (2004): Simultaneous expression of furin and Vascular Endothelial Growth Factor in human oral tongue squamous cell carcinoma progression. Clin. Cancer Res. 10, 4480–4488.

    Klein-Szanto A. J. , 'Simultaneous expression of furin and Vascular Endothelial Growth Factor in human oral tongue squamous cell carcinoma progression ' (2004 ) 10 Clin. Cancer Res. : 4480 -4488.

    • Search Google Scholar
  • Mohammed, S. I., Bennett, P. F., Craig, B. A., Glickman, N. W., Mutsaers, A. J., Snyder, P. W., Widmer, W. R., De Gortari, A. E., Bonney, P. L. and Knapp, D. W. (2002): Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res. 62, 356–358.

    Knapp D. W. , 'Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer ' (2002 ) 62 Cancer Res. : 356 -358.

    • Search Google Scholar
  • Mackiewicz, J. and Kwinta, Ł. (2010): New targeted therapies in the treatment of patients with metastatic melanoma. Wspólcz. Onkol. 14, 15–22.

    Kwinta , 'New targeted therapies in the treatment of patients with metastatic melanoma ' (2010 ) 14 Wspólcz. Onkol. : 15 -22.

    • Search Google Scholar
  • Mărgăritescu, C., Pirici, D., Simionescu, C., Mogoantă, L., Raica, M., Stîngă, A., Ciurea, R., Stepan, A., Stîngă, A. and Ribatti, D. (2009): VEGF and VEGFRs expression in oral squamous cell carcinoma. Rom. J. Morphol. Embryol. 50, 527–548.

    Ribatti D. , 'VEGF and VEGFRs expression in oral squamous cell carcinoma ' (2009 ) 50 Rom. J. Morphol. Embryol. : 527 -548.

    • Search Google Scholar
  • Michailidon, E. Z., Markopoulos, A. K. and Antoniades, D. Z. (2008): Mast cell and angiogenesis in oral malignant and premalignant lesions. Open. Dent. J. 2, 126–132.

    Antoniades D. Z. , 'Mast cell and angiogenesis in oral malignant and premalignant lesions ' (2008 ) 2 Open. Dent. J. : 126 -132.

    • Search Google Scholar
  • Polverini, P. J. (2002): Angiogenesis in health and disease: Insights into basic mechanisms and therapeutic opportunities. J. Dent. Educ. 8, 962–975.

    Polverini P. J. , 'Angiogenesis in health and disease: Insights into basic mechanisms and therapeutic opportunities ' (2002 ) 8 J. Dent. Educ. : 962 -975.

    • Search Google Scholar
  • Rawlings, N. G., Simko, E., Bebchuk, T., Caldwell, S. J. and Singh, B. (2003): Localization of integrin alpha(v)beta3 and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in cutaneous and oral melanomas of dog. Histol. Histopathol. 3, 819–826.

    Singh B. , 'Localization of integrin alpha(v)beta3 and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in cutaneous and oral melanomas of dog ' (2003 ) 3 Histol. Histopathol. : 819 -826.

    • Search Google Scholar
  • Roselli, M., Mineo, T. C., Basili, S., Mariotti, S., Martini, F., Bellotti, A., Ambrogi, V., Spila, A., D’Alessandro, R., Gazzaniga, P. P., Guadagni, F. and Ferroni, P. (2003): Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers. J. Thromb. Haemost. 89, 177–184.

    Ferroni P. , 'Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers ' (2003 ) 89 J. Thromb. Haemost. : 177 -184.

    • Search Google Scholar
  • Sacewicz, I., Wiktorska, M., Wysocki, T. and Niewiarowska, J. (2009): Mechanisms of cancer angiogenesis. Postepy Hig. Med. Dosw. 63, 159–168.

    Niewiarowska J. , 'Mechanisms of cancer angiogenesis ' (2009 ) 63 Postepy Hig. Med. Dosw. : 159 -168.

    • Search Google Scholar
  • Sapierzyński, R., Malicka, E., Bielecki, W., Krawiec, M., Osińska, B., Sendecka, H. and Sobczak-Filipiak, M. (2007): Oral tumors in dogs and cats: retrospective review of 143 cases. Medycyna Wet. 63, 1196–1199.

    Sobczak-Filipiak M. , 'Oral tumors in dogs and cats: retrospective review of 143 cases ' (2007 ) 63 Medycyna Wet. : 1196 -1199.

    • Search Google Scholar
  • Scheidegger, P., Weiglhofer, W., Suarez, S., Kaser-Hotz, B., Steiner, R., Ballmer-Hofer, K. and Jaussi, R. (1999): Vascular endothelial growth factor (VEGF) and its receptors in tumorbearing dogs. Biol. Chem. 380, 1449–1454.

    Jaussi R. , 'Vascular endothelial growth factor (VEGF) and its receptors in tumorbearing dogs ' (1999 ) 380 Biol. Chem. : 1449 -1454.

    • Search Google Scholar
  • Shiomitsu, K., Johnson, C. L., Malarkey, D. E., Pruitt, A. F. and Thrall, D. E. (2009): Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours. Vet. Comp. Oncol. 7, 106–114.

    Thrall D. E. , 'Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours ' (2009 ) 7 Vet. Comp. Oncol. : 106 -114.

    • Search Google Scholar
  • Smedley, R. C., Spangler, W. L., Esplin, D. G., Kitchell, B. E., Bergman, P. J., Ho, H. Y., Bergin, I. L. and Kiupel, M. (2011): Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation. Vet. Pathol. 48, 54–72.

    Kiupel M. , 'Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation ' (2011 ) 48 Vet. Pathol. : 54 -72.

    • Search Google Scholar
  • Smith, B. D., Smith, G. L., Carter, D., Sasaki, C. T. and Haffty, B. G. (2000): Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J. Clin. Oncol. 18, 2046–2052.

    Haffty B. G. , 'Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma ' (2000 ) 18 J. Clin. Oncol. : 2046 -2052.

    • Search Google Scholar
  • Sobczyńska-Rak, A. (2012): The role of VEGF in process of neovasculogenesis. In: Ran, S. (ed.) Tumor Angiogenesis. Intech, Rijeka, Croatia. pp. 181–196.

    Sobczyńska-Rak A. , '', in Tumor Angiogenesis , (2012 ) -.

  • Sobczyńska-Rak, A., Polkowska, I., Śmiech, A. and Sobolewska, E. (2009): Angiogenesis in malignant oral-cavity tumours in dogs. Bull. Vet. Inst. Pulawy 53, 463–466.

    Sobolewska E. , 'Angiogenesis in malignant oral-cavity tumours in dogs ' (2009 ) 53 Bull. Vet. Inst. Pulawy : 463 -466.

    • Search Google Scholar
  • Szala, S. (2009): Angiogenesis and immune suppression: yin and yang of tumor progression? Postepy Hig. Med. Dosw. 63, 598–612.

    Szala S. , 'Angiogenesis and immune suppression: yin and yang of tumor progression ' (2009 ) 63 Postepy Hig. Med. Dosw. : 598 -612.

    • Search Google Scholar
  • Takahashi, H. and Shibuya, M. (2005): The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. 109, 227–241.

    Shibuya M. , 'The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions ' (2005 ) 109 Clin. Sci. : 227 -241.

    • Search Google Scholar
  • Taylor, K. H., Smith, A. N., Higginbotham, M., Schwartz, D. D., Carpenter, D. M. and Whitley, E. M. (2007): Expression of vascular endothelial growth factor in canine oral malignant melanoma. Vet. Comp. Oncol. 5, 208–218.

    Whitley E. M. , 'Expression of vascular endothelial growth factor in canine oral malignant melanoma ' (2007 ) 5 Vet. Comp. Oncol. : 208 -218.

    • Search Google Scholar
  • Troy, G. C., Panciera, D., Lanz, O., Robertson, J. L. and Ward, D. L. (2006): Endostatin and Vascular Endothelial Growth Factor concentrations in healthy dogs, dogs with selected neoplasia, and dogs with nonneoplastic diseases. J. Vet. Intern. Med. 20, 144–150.

    Ward D. L. , 'Endostatin and Vascular Endothelial Growth Factor concentrations in healthy dogs, dogs with selected neoplasia, and dogs with nonneoplastic diseases ' (2006 ) 20 J. Vet. Intern. Med. : 144 -150.

    • Search Google Scholar
  • Uchida, N., Nagai, K., Sakurada, Y. and Shirota, K. (2008): Distribution of VEGF and flt-1 in the normal dog tissues. J. Vet. Med. Sci. 70, 1273–1276.

    Shirota K. , 'Distribution of VEGF and flt-1 in the normal dog tissues ' (2008 ) 70 J. Vet. Med. Sci. : 1273 -1276.

    • Search Google Scholar
  • Ugurel, S., Rappl, G., Tilgen, W. and Reinhold, U. (2001): Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J. Clin. Oncol. 19, 577–583.

    Reinhold U. , 'Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival ' (2001 ) 19 J. Clin. Oncol. : 577 -583.

    • Search Google Scholar
  • Volk, L. D., Flister, M. J., Bivens, Ch. M., Stutzman, A., Desai, N., Trieu, V. and Ran, S. (2008): Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-Vascular Endothelial Growth Factor A therapy. Neoplasia 10, 613–623.

    Ran S. , 'Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-Vascular Endothelial Growth Factor A therapy ' (2008 ) 10 Neoplasia : 613 -623.

    • Search Google Scholar
  • Wasik-Szczepanek, E. and Koczkodaj, D. (2008): Vascular endothelial growth factor (VEGF) and its role in B-cell chronic lymphocytic leukemia. Acta Haematol. Pol. 39, 197–205.

    Koczkodaj D. , 'Vascular endothelial growth factor (VEGF) and its role in B-cell chronic lymphocytic leukemia ' (2008 ) 39 Acta Haematol. Pol. : 197 -205.

    • Search Google Scholar
  • Wergin, M. C. and Kaser-Hotz, B. (2004): Plasma Vascular Endothelial Growth Factor (VEGF) measured in seventy dogs with spontaneously occurring tumours. In Vivo 18, 15–20.

    Kaser-Hotz B. , 'Plasma Vascular Endothelial Growth Factor (VEGF) measured in seventy dogs with spontaneously occurring tumours ' (2004 ) 18 In Vivo : 15 -20.

    • Search Google Scholar
  • Wergin, M. C., Roos, M., Inteeworn, N., Laluhovà, D., Allemann, K. and Kaser-Hotz, B. (2006): The influence of fractionated radiation therapy on plasma vascular endothelial growth factor (VEGF) concentration in dogs with spontaneous tumors and its impact on outcome. Radiother. Oncol. 2, 239–244.

    Kaser-Hotz B. , 'The influence of fractionated radiation therapy on plasma vascular endothelial growth factor (VEGF) concentration in dogs with spontaneous tumors and its impact on outcome ' (2006 ) 2 Radiother. Oncol. : 239 -244.

    • Search Google Scholar

Author information is available in PDF.
Please, download the file from HERE.

The manuscript preparation instructions is available in PDF.
Please, download the file from HERE.

Senior editors

Editor-in-Chief: Mária BENKŐ

Managing Editor: András SZÉKELY

Editorial Board

  • Béla DÉNES (National Food Chain Safety Office, Budapest Hungary)
  • Edit ESZTERBAUER (Veterinary Medical Research Institute, Budapest, Hungary)
  • Hedvig FÉBEL (National Agricultural Innovation Centre, Herceghalom, Hungary)
  • László FODOR (University of Veterinary Medicine, Budapest, Hungary)
  • Balázs HARRACH (Veterinary Medical Research Institute, Budapest, Hungary)
  • Peter MASSÁNYI (Slovak University of Agriculture in Nitra, Nitra, Slovak Republic)
  • Béla NAGY (Veterinary Medical Research Institute, Budapest, Hungary)
  • Tibor NÉMETH (University of Veterinary Medicine, Budapest, Hungary)
  • Zsuzsanna NEOGRÁDY (University of Veterinary Medicine, Budapest, Hungary)
  • Alessandra PELAGALLI (University of Naples Federico II, Naples, Italy)
  • Kurt PFISTER (Ludwig-Maximilians-University of Munich, Munich, Germany)
  • László SOLTI (University of Veterinary Medicine, Budapest, Hungary)
  • József SZABÓ (University of Veterinary Medicine, Budapest, Hungary)
  • Péter VAJDOVICH (University of Veterinary Medicine, Budapest, Hungary)
  • János VARGA (University of Veterinary Medicine, Budapest, Hungary)
  • Štefan VILČEK (University of Veterinary Medicine in Kosice, Kosice, Slovak Republic)
  • Károly VÖRÖS (University of Veterinary Medicine, Budapest, Hungary)
  • Herbert WEISSENBÖCK (University of Veterinary Medicine, Vienna, Austria)
  • Attila ZSARNOVSZKY (Szent István University, Gödöllő, Hungary)

ACTA VETERINARIA HUNGARICA
Institute for Veterinary Medical Research
Centre for Agricultural Research
Hungarian Academy of Sciences
P.O. Box 18, H-1581 Budapest, Hungary
Phone: (36 1) 467 4081 (ed.-in-chief) or (36 1) 213 9793 (editor) Fax: (36 1) 467 4076 (ed.-in-chief) or (36 1) 213 9793

Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Current Contents: Agriculture, Biology and Environmental Sciences
  • Elsevier Science Navigator
  • Focus On: Veterinary Science and Medicine
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Science Citation Index
  • Science Citation Index Expanded (SciSearch)
  • SCOPUS
  • The ISI Alerting Services
  • Zoological Abstracts

 

2020  
Total Cites 987
WoS
Journal
Impact Factor
0,955
Rank by Veterinary Sciences 101/146 (Q3)
Impact Factor  
Impact Factor 0,920
without
Journal Self Cites
5 Year 1,164
Impact Factor
Journal  0,57
Citation Indicator  
Rank by Journal  Veterinary Sciences 93/166 (Q3)
Citation Indicator   
Citable 49
Items
Total 49
Articles
Total 0
Reviews
Scimago 33
H-index
Scimago 0,395
Journal Rank
Scimago Veterinary (miscellaneous) Q2
Quartile Score  
Scopus 355/217=1,6
Scite Score  
Scopus General Veterinary 73/183 (Q2)
Scite Score Rank  
Scopus 0,565
SNIP  
Days from  145
sumbission  
to acceptance  
Days from  150
acceptance  
to publication  
Acceptance 19%
Rate

 

2019  
Total Cites
WoS
798
Impact Factor 0,991
Impact Factor
without
Journal Self Cites
0,897
5 Year
Impact Factor
1,092
Immediacy
Index
0,119
Citable
Items
59
Total
Articles
59
Total
Reviews
0
Cited
Half-Life
9,1
Citing
Half-Life
9,2
Eigenfactor
Score
0,00080
Article Influence
Score
0,253
% Articles
in
Citable Items
100,00
Normalized
Eigenfactor
0,09791
Average
IF
Percentile
42,606
Scimago
H-index
32
Scimago
Journal Rank
0,372
Scopus
Scite Score
335/213=1,6
Scopus
Scite Score Rank
General Veterinary 62/178 (Q2)
Scopus
SNIP
0,634
Acceptance
Rate
18%

 

Acta Veterinaria Hungarica
Publication Model Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Printed Color Illustrations 40 EUR (or 10 000 HUF) + VAT / piece
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 696 EUR / 872 USD
Print + online subscription: 804 EUR / 1004 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Veterinaria Hungarica
Language English
Size A4
Year of
Foundation
1951
Publication
Programme
2020 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-6290 (Print)
ISSN 1588-2705 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Feb 2021 14 0 0
Mar 2021 2 0 0
Apr 2021 6 0 0
May 2021 3 1 1
Jun 2021 5 0 0
Jul 2021 7 0 0
Aug 2021 0 0 0